A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivo

Autor: Giannakopoulou, Eirini Chrysovalantou, Lehander, Madeleine, Virding Culleton, Stina, Yang, Weiwen, Li, Yingqian, Kärpänen, Terhi Hannele, Yoshizato, Tetsuichi, Rustad, Even Holth, Nielsen, Morten Milek, Bollineni, Ravi Chand, Tran, Trung, Delic-Sarac, Marina, Gjerdingen, Thea Johanne, Douvlataniotis, Dimitrios Karolos, Laos, Maarja, Hillen, Amy, Ali, Muhammad, Mazzi, Stefania, Chin, Desmond Wai Loon, Mehta, Adi, Holm, Jeppe Sejerø, Bentzen, Amalie Kai, Bill, Marie, Griffioen, Marieke, Gedde-Dahl, Tobias, Lehmann, Sören, Jacobsen, Sten Eirik W., Woll, Petter S., Olweus, Johanna

Publikováno v: Giannakopoulou, Eirini Chrysovalantou Lehander, Madeleine Virding Culleton, Stina Yang, Weiwen Li, Yingqian Kärpänen, Terhi Hannele Yoshizato, Tetsuichi Rustad, Even Holth Nielsen, Morten Milek Bollineni, Ravi Chand Tran, Trung Delic-Sarac, Marina Gjerdingen, Thea Johanne Douvlataniotis, Dimitrios Karolos Laos, Maarja Hillen, Amy Ali, Muhammad Mazzi, Stefania Chin, Desmond Wai Loon Mehta, Adi Holm, Jeppe Sejerø Bentzen, Amalie Kai Bill, Marie Griffioen, Marieke Gedde-Dahl, Tobias Lehmann, Sören Jacobsen, Sten Eirik W. Woll, Petter S. Olweus, Johanna . A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivo. Nature Cancer. 2023, 4(10)
Nature Cancer

Externí odkaz: http://hdl.handle.net/10852/108741